Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 577, doi. 10.1007/s40265-018-0895-5
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 5
Results: 9
1
2
Bictegravir: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 601, doi. 10.1007/s40265-018-0896-4
- By:
- Publication type:
- Article
3
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 589, doi. 10.1007/s40265-018-0894-6
- By:
- Publication type:
- Article
4
Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 609, doi. 10.1007/s40265-018-0893-7
- By:
- Publication type:
- Article
5
Correction to: Eculizumab: A Review in Generalized Myasthenia Gravis.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 607, doi. 10.1007/s40265-018-0889-3
- By:
- Publication type:
- Article
6
Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 567, doi. 10.1007/s40265-018-0887-5
- By:
- Publication type:
- Article
7
BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 549, doi. 10.1007/s40265-018-0884-8
- By:
- Publication type:
- Article
8
Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 543, doi. 10.1007/s40265-018-0879-5
- By:
- Publication type:
- Article
9
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
- Published in:
- Drugs, 2018, v. 78, n. 5, p. 525, doi. 10.1007/s40265-018-0874-x
- By:
- Publication type:
- Article